Comparing anti-inflammatory drops after laser for glaucoma
Part of Eyes & vision clinical trials.
This study tests whether an anti-inflammatory eye drop alone works better than a combination of anti-inflammatory and steroid eye drops to reduce pain and swelling after a laser treatment for open-angle glaucoma. The goal is to find the safest and most effective way to manage recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with open-angle glaucoma.
- Your eye pressure has been above 16 mmHg on two separate visits, one month apart.
- You have at least 20/200 vision or better in one eye.
- You have not had any eye surgery or other eye problems treated in the last six months.
- You are not allergic to ketorolac or fluorometholone, and have not used them in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures inflammation markers on the eye surface in people with primary open-angle glaucoma or ocular hypertension who use certain glaucoma drops. The results may help doctors understand how these drops affect the eye and inflammation.
This study is looking at people with glaucoma or high eye pressure who are about to have glaucoma surgery. The goal is to understand more about their condition and how it responds after stopping their usual eye drops for a short time before surgery.
This study tests whether three different eye drop treatments (netarsudil, latanoprost, or both together) can improve blood flow to the white part of the eye and the retina. It may help people with high eye pressure or who are glaucoma suspects better understand how these treatments work.
This trial compares two first treatments—laser therapy (SLT) or daily eye drops (latanoprost)—to lower eye pressure in people newly diagnosed with open-angle glaucoma or high eye pressure. It aims to find which approach works better as an initial therapy.
This study tests an eye drop called BL1332 to see if it can help reduce pain after photorefractive keratectomy (PRK), a type of laser eye surgery. If you are scheduled for PRK and are between 18 and 58 years old, you may be eligible.
This trial tests three different anti-inflammatory eye drops to see which works best for pain and swelling after cataract surgery. You may join if you are scheduled for cataract surgery only, and you can apply the drops yourself or have help.
Hear when a new Ocular Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.